Genic (123330) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Genic (123330) reported revenue of 78.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202578.2 billion KRW15.0 billion KRW18.9 billion KRW[source]
202449.9 billion KRW6.0 billion KRW7.6 billion KRW[source]
202328.1 billion KRW-4.0 billion KRW-4.4 billion KRW[source]
202231.4 billion KRW-3.2 billion KRW-3.3 billion KRW[source]
202138.4 billion KRW-3.9 billion KRW-4.3 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202556.5 billion KRW15.5 billion KRW41.0 billion KRW[source]
202438.1 billion KRW16.0 billion KRW22.2 billion KRW[source]
202323.4 billion KRW11.9 billion KRW11.5 billion KRW[source]
202230.3 billion KRW14.4 billion KRW15.9 billion KRW[source]
202145.4 billion KRW26.1 billion KRW19.3 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
202520.7 billion KRW-3.4 billion KRW-5.3 billion KRW[source]
2024272 million KRW-1.5 billion KRW818 million KRW[source]
2023-268 million KRW1.8 billion KRW-3.2 billion KRW[source]
2022186 million KRW-3.9 billion KRW-10.2 billion KRW[source]
20212.6 billion KRW12.1 billion KRW-3.7 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice